Innoviva (NASDAQ: INVA) net income
Innoviva reported a net profit of $271.2m for fiscal 2025, 1,059.2% more than in fiscal 2024 ($23.4m). Its net margin was 65.9%. Earnings per share were $4.02.
Innoviva's best year of the last 10 was fiscal 2018. The biggest drop was in fiscal 2024, −87.0%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | $271.2m | +1,059.2% | 65.9% | $4.02 |
| 2024 | $23.4m | −87.0% | 6.5% | $0.37 |
| 2023 | $179.7m | −18.4% | 57.9% | $2.75 |
| 2022 | $220.3m | −40.3% | 66.5% | $3.07 |
| 2021 | $368.8m | +25.5% | 94.1% | $3.24 |
| 2020 | $293.8m | +53.8% | 87.2% | $2.21 |
| 2019 | $191.0m | −53.0% | 73.2% | $1.55 |
| 2018 | $406.3m | +202.6% | 155.7% | $3.92 |
| 2017 | $134.3m | +125.5% | 61.8% | $1.25 |
| 2016 | $59.5m | — | 44.6% | $0.54 |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Innoviva net income compared with its sector
By net income for its latest fiscal year, Innoviva ranks 77th of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of Innoviva, 65.9%.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 75th | Aurinia Pharmaceuticals | $287.2m | 101.5% |
| 76th | BeOne Medicines | $286.9m | 5.4% |
| 77th | Innoviva | $271.2m | 65.9% |
| 78th | Chemed | $265.2m | 10.5% |
| 79th | BioCryst Pharmaceuticals | $263.9m | 30.2% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of Innoviva
- How much did Innoviva earn in fiscal 2025?
- Innoviva reported a net profit of $271.2m for fiscal 2025. In fiscal 2024 it reported a net profit of $23.4m.
- What are the earnings per share of Innoviva?
- They were $4.02 in fiscal 2025, compared with $0.37 in fiscal 2024.
- What is the net margin of Innoviva?
- In fiscal 2025 its net profit was 65.9% of its revenue.
- What was the most profitable year for Innoviva?
- Of its last 10 fiscal years, fiscal 2018, with $406.3m.
- Where does Innoviva rank in its sector by net income?
- It ranks 77th of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for Innoviva come from?
- From the annual report (Form 10-K) that Innoviva files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Innoviva files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Innoviva: the Innoviva page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.